| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
2 companies
Davis Blaine is a Chief Financial Officer at Cartesian Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 3 sells.
Estimated insider holdings value: $1.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | RNAC Cartesian Therapeutics, Inc. | Chief Financial Officer | Sell | 10,591 | $6.82 | $72,227.44 | -8.0% | -11.4% | - | |
| Jan 6, 2025 | RNAC Cartesian Therapeutics, Inc. | Chief Financial Officer | Sell | 7,989 | $16.78 | $134,035.55 | -4.0% | -42.7% | -60.1% | |
| Sep 22, 2020 | TARA Protara Therapeutics, Inc. | Chief Financial Officer | Buy | 1,481 | $16.91 | $25,037.79 | New | - | - |